Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4 -amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3 -amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole
{"title":"Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4 -amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3 -amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole","authors":"C.P. Coyne","doi":"10.17303/jcrto.2013.2.203","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15189,"journal":{"name":"Journal of Cancer Research and Therapeutic Oncology","volume":"24 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Research and Therapeutic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17303/jcrto.2013.2.203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}